New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 5, 2014
06:31 EDTKPTIKaryopharm reports FY13 EPS ($5.59), may not compare to consensus ($2.93)
Net loss includes stock-based compensation expense of $3.8M and $653,000 for the years ended December 31, 2013 and 2012, respectively.
News For KPTI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
September 29, 2014
08:08 EDTKPTIKaryopharm announces clinical data for Selinexor
Subscribe for More Information
September 26, 2014
09:23 EDTKPTIKaryopharm to host conference call
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use